Hongtai Capital Holdings is a full life cycle comprehensive investment management platform.
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Hongtai Capital Holdings is a private equity and venture capital firm that specializes direct and fund of funds investments through Aplus Fund and Aplus Capital. It specializes in direct investments covering angel and growth capital stage investments in big data, artificial intelligence, financial technology, consumer upgrade, cultural entertainment, internet, internet of things, and intelligent manufacturing sectors for Aplus Fund Hongtai Capital specializes in direct and fund of funds investments through mature stage investments, acquisitions, and industry consolidation in healthcare, new healthcare, health, medical treatment, biotechnology, healthcare education, next generation health diagnostics, alternative energy, advanced manufacturing in Shandong Province in China for Aplus Capital. It prefers to invest in companies with IPO potential for Aplus Capital. Hongtai Capital typically makes joint acquisitions and acquire majority stakes in portfolio companies for acquisitions. It seeks to exit though selling or injecting into listed companies for acquisition of majority stakes. Hongtai Capital acquires minority stakes and prefers to exit through reorganization and listing. It also specializes in incubation, seed, start-up, early, middle, expansion, late stage, mergers and acquisitions investments for industry consolidation. Hongtai Capital typically invests in relaxation entertainment, media, culture, education, cultural sports, technology, mobile internet, network security, smart hardware, telecommunication, consumer, online consumer, food, beverage, leisure, environmental protection, mobile agriculture, environment-friendly new materials, creativity, chain-style business, retail, , and sensor technology, finance, internet finance, mobile internet products overturning industry models, new consumer, new technology, new finance, and new education sectors. It invests in non-listed companies and in companies listed in the new third board. It seeks to invest in Silicon Valley and Boston, U.S.A. Hongtai Capital typically invests CNY 0.5 million (USD 74,903.00) to CNY 500 million (USD 81.61 million) per portfolio company. It prefers to invest in companies with a maximum valuation of USD 100 million. Sheng Taisheng and Yu Minhong founded Hongtai Capital on November 26, 2014. It has its headquarters in Beijing in China.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2020 | Guoxing Aerospace | Series A | 21.4M |
12/2016 | NovuMind | Series A | 15.2M |
3/2018 | Deepleaper | Series A | - |
7/2018 | Reexen Technology | Seed Round | - |
2/2019 | Sigma Squares Tech | Seed Round | 1.5M |
10/2017 | Edianyun | Series B | 18M |
3/2018 | Edianyun | Series C | 32M |
9/2020 | Showmac Tech | Series A | 15M |
2/2021 | Meishubao | Series D | 40M |
1/2019 | Shuxi Technology | Angel Round | 3M |
7/2017 | Xiaomai | Series A | 18.5M |
8/2019 | Xyb2b | Series B | 100M |
10/2020 | Hinova Pharma | Series C | 0 |
3/2018 | Chaohi | Series A | - |
3/2016 | Yongqianbao | Series B | - |
12/2017 | Shenzhen Sinoagri E-Commerce | Series A | - |
6/2017 | Tianjin Galaxy Cool Media | Series B | 0 |
6/2018 | Dtwave | Series A | 22M |
2/2018 | Dorabot | Series A | - |
10/2017 | SoundAI | Series A | 15M |
4/2018 | Xiaoniujh.com | Series A | - |
4/2016 | Tricorn | Angel Round | 0 |
3/2019 | Haizol.com | Series B | 14.9M |
1/2022 | Accro Bioscience | Series B | 0 |
5/2018 | Intengine Technology | Series A | - |
10/2021 | UISEE | Venture Round | - |
3/2020 | Berxel | Series A | 14.1M |
12/2018 | Xyb2b | Series B | - |
3/2018 | Locals | Series A | 15.8M |
12/2018 | Yanjiyou | Series B | 14.5M |
4/2019 | Edu Dreamers | Angel Round | - |
7/2019 | Qyuns Therapeutics | Series B | 20M |
10/2016 | SoundAI | Seed Round | 24M |
10/2018 | XQIAO | Series B | 20.3M |
7/2019 | CGeneTech | Series A | 14.5M |
5/2018 | Ultrain | Angel Round | - |
1/2018 | Kuaile De Dan | Series A | - |
12/2022 | Mymro | Series B | - |
1/2018 | Harvest Capital Management | Funding Round | 480M |
8/2022 | Taoyuan Technology | Seed Round | 13.2M |
8/2019 | i-KINGTEC | Series A | - |
6/2017 | Ptmind | Series B | 12M |
11/2018 | Hanyi Fonts | Series A | 21.6M |
7/2018 | Pony.ai | Series A | 0 |
8/2016 | Yongqianbao | Series B | 23.4M |
12/2016 | Dtwave | Seed Round | 6.5M |
7/2020 | KK Group | Series E | 0 |
4/2019 | Heqiauto.com | Series A | - |
11/2017 | Nreal | Angel Round | - |
1/2021 | Newlink | Series E | 100M |
12/2018 | PENSEES | Series A | 2.9M |
9/2015 | Dorabot | Series A | - |
1/2022 | Newlinks Technology | Series E | - |
8/2021 | JOINN Biologics | Series B | 150M |
1/2022 | Newlinks Technology | Series E | - |
1/2022 | Accro Bioscience | Series B | 0 |
10/2021 | UISEE | Venture Round | - |
8/2021 | JOINN Biologics | Series B | 0 |
2/2021 | Meishubao | Series D | 0 |
1/2021 | Newlink | Series E | 0 |
10/2020 | Hinova Pharma | Series C | 0 |
9/2020 | Showmac Tech | Series A | 0 |
7/2020 | Guoxing Aerospace | Series A | 0 |
7/2020 | KK Group | Series E | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|